Cergentis
Maurijn received his PhD in the field of developmental biology studying vertebrate skeletogenesis at Wageningen University. He previously worked at the University of Liège where he studied pancreatic ductal adenocarcinoma through the development of zebrafish models.
At Cergentis, Maurijn works as part of the service projects team performing TLA.
This person is not in any offices
Cergentis
1 followers
Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest.